Lawrence Klein
Chief Executive Officer at Oruka Therapeutics; CBO & COO at CRISPR Therapeutics AG; Director at Jade Biosciences. Based in Menlo Park, California.
- Rank
- 1615th of 14,644
- Companies held
- 4
- Largest holding
- ORKA, 98.8% of total
- Latest SEC filing
- Nov 2, 2026
What the $91.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Oruka Therapeutics ORKA Common Stock | Directly | 923,128 | $97.57 | $90.1M | 98.8% | Form 4, Nov 2, 2026 |
| CRISPR Therapeutics AG CRSP Common Shares | Directly | 26,797 | $38.93 | $1.0M | 1.1% | Form 4, Mar 14, 2022 |
| Jade Biosciences JBIO Common Stock | Directly | 2,463 split-adjusted | $15.06 | $37K | 0.0% | Form 3, Apr 28, 2025 |
| Jasper Therapeutics JSPR Voting Common Stock | Directly | 82 split-adjusted | $10.75 | $878 | 0.0% | Form 4, Oct 12, 2022 |
Share counts are the amounts Lawrence Klein reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Sold | ORKA | 6,466 | $94.77 | $613K | View |
| Nov 2, 2026 | Sold | ORKA | 15,036 | $95.64 | $1.4M | View |
| Nov 2, 2026 | Sold | ORKA | 2,442 | $96.70 | $236K | View |
| Nov 2, 2026 | Sold | ORKA | 756 | $97.45 | $74K | View |
| Nov 2, 2026 | Sold | ORKA | 300 | $98.40 | $30K | View |
| Oct 1, 2026 | Sold | ORKA | 16,246 | $83.40 | $1.4M | View |
| Oct 1, 2026 | Sold | ORKA | 8,554 | $84.03 | $719K | View |
| Oct 1, 2026 | Sold | ORKA | 200 | $84.78 | $17K | View |
| Sep 15, 2026 | Sold | ORKA | 2,452 | $95.71 | $235K | View |
| Sep 1, 2026 | Sold | ORKA | 4,800 | $92.44 | $444K | View |
| Sep 1, 2026 | Sold | ORKA | 63,596 | $91.90 | $5.8M | View |
| Sep 1, 2026 | Sold | ORKA | 6,604 | $90.79 | $600K | View |
| Jun 15, 2026 | Sold | ORKA | 1,729 | $69.69 | $120K | View |
| Mar 16, 2026 | Sold | ORKA | 1,729 | $41.30 | $71K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1612 | Victoria Valenzuela Director, AppLovin. Palo Alto, CA | $91.4M |
| 1613 | Gilbert L. Baird III Director, The RealReal. New York, NY | $91.2M |
| 1614 | Yahui Zhou Director, Opay | $91.2M |
| 1615 | Lawrence Klein Chief Executive Officer, Oruka Therapeutics. Menlo Park, CA | $91.2M |
| 1616 | Junli Yang DIRECTOR & CHAIRWOMAN, TOP Financial Group | $91.1M |
| 1617 | Laurence Zuriff Director, Xometry. North Bethesda, MD | $91.1M |
| 1618 | Angela K. Janssen Insider, Heartland Express. North Liberty, IA | $91.1M |
Other Oruka Therapeutics insiders
All ORKA insiders- Laura Sandler$23.0MChief Operating Officer. #4679 overall
- Larry Todd Edwards$9.8MChief Commercial Officer. #6613 overall
- Cameron Turtle$693KDirector. #2431 overall
Questions
How much stock does Lawrence Klein own?
Lawrence Klein holds $91,150,781 in listed stock based on SEC filings and current prices, mostly Oruka Therapeutics (ORKA). That ranks 1615th on the Stock Rich List.
Is this Lawrence Klein's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Lawrence Klein last buy or sell stock?
The most recent open-market trade on file is a sale of 6,466 ORKA shares on Nov 2, 2026 at $94.77.